05:30 AM EST, 02/25/2026 (MT Newswires) -- Tandem Diabetes Care ( TNDM ) said Wednesday it priced a private placement of $265 million in zero-interest convertible senior notes maturing March 15, 2032, for about $256.7 million in expected net proceeds.

The placement was increased from an originally planned $200 million target and includes an option for initial buyers to acquire up to $35 million in additional debt.

The company expects the offering to close Friday and plans to use the net proceeds to pay the roughly $13.5 million cost of certain capped call transactions, among other things.